OOIR: Observatory of International Research

Papers

(The median citation count of International Journal of Tuberculosis and Lung Disease is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Alcohol use disorder and TB survivor health	211
Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials	110
Occupational safety and health for respiratory health: a comprehensive approach for an often-forgotten issue	94
An Inca trail to the Holy Grail: digital medication adherence support for TB care	59
Quality assessment of clinical practice guidelines for the management of wheezing disorders in children	43
Aspergillus infection is an important complication of post-TB bronchiectasis	43
Response to: The pressing need for standardised diagnostic criteria for obstructive ventilatory impairment in adults and children	42
A home-based care programme for rifampicin-resistant TB	36
A cross-sectional study of risk factors for TB among socially marginalised people	34
After DOT, the brave new world?	33
Low serum levels of anti-TB drugs in a high TB setting	26
TB diagnosis and treatment during the COVID-19 pandemic	25
COVID-19 effect on TB presentation and outcome	25
Screening for TB infection: the operator´s impact	25
A large cohort study of TB of the central nervous system: clinical outcomes	24
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era	22
Establishing proof of concept for utility of Trueprep^®-extracted DNA in line-probe assay testing	22
Recent developments in the diagnosis and treatment of extrapulmonary non-tuberculous mycobacterial diseases	20
Clinical standards for the diagnosis, treatment and prevention of TB infection	20
Stool testing for pulmonary TB diagnosis in adults	19
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up	18
Use of interactive messaging to reduce pre-diagnosis loss to follow-up for TB care	17
Literature Highlights	16
The cascade of care for household contacts of people with drug-resistant TB	16
Dactylitis due to accidental needle-stick injury with a BCG-loaded syringe	15

Tackling the many layers of stigma is essential for the “End TB Strategy”	15
Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB?	15
Family directly observed therapy for children with drug-resistant TB	14
A study of persistent symptoms and pulmonary function at 3 months post moderate or severe COVID-19 in Angola	14
Active case-finding of pulmonary TB in an urban emergency department	14
High-dose proton pump inhibitors are associated with hospitalisation in bronchiectasis exacerbation	13
Shorter regimens for multidrug-/rifampicin-resistant TB	13
Targeted TB control in migrants to low-burden countries	13
Chest X-ray scoring to screen for chronic pulmonary aspergillosis in patients with a history of pulmonary TB	13
Flupentixol/melitracen for chronic refractory cough after treatment failure with other neuromodulators	13
The impact of sputum quality on Xpert positivity in active case-finding for TB	12
High mortality due to gastrointestinal TB in HIV and non-HIV patients	12
Clinical profile and outcomes of paediatric central nervous system tuberculomas	12
Digital medication adherence technology: towards personalised TB care	11
Dr Christopher Zishiri	11
Prevalence of tobacco smoking and cannabis use in young men in South Africa	11
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB	11
Literature Highlights	11
Improving enrolment for TB preventive treatment	11
The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB	11
QTc prolongation with bedaquiline treatment for drug-resistant pulmonary TB in a programmatic setting	10
Geographical differences in chronic obstructive pulmonary disease mortality trends by sex, Spain, 1980–2021	10
Armand Van Deun ‐ pioneering public health physician (1953–2023)	10
Anti-tuberculosis activity of morusin: a promising flavonoid from white mulberry	10
A bold new future for the IJTLD	10
Reply to ‘Estimating TB survival ‐ mind the immortal-time gap’	10
QT prolongation in the STREAM Stage 1 Trial	9
Impact of the bacillary load on the accuracy of rifampicin resistance results by Xpert^® MTB/RIF	9
Post-TB lung disease in three African countries	9
Decline in TB incidence during the COVID-19 pandemic	9
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB	9
The impact of the COVID-19 pandemic on TB in a low TB burden setting	9
Efflux pump gene expression study using RNA-seq in multidrug-resistant TB	8
Limitations of using tuberculin skin test to screen for TB in patients with psoriasis	8
The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya	8
TB in ageing populations: lessons from Japan and Korea	8
Did public-private partnerships reduce TB incidence in Korea?	8
An epidemiological analysis of TB trends in native and migrant populations, New Mexico, 1993–2021	8
Incidence of tuberculous infection in a TB-endemic city	8
Chronic pulmonary aspergillosis: a neglected post-TB lung disease	8
Metabolic characterisation of adult Ugandan patients with TB and diabetes mellitus comorbidity	7
Clinical standards for drug-susceptible TB: putting patients first	7
WHO target product profiles for TB preventive treatment	7
TB and COVID-19 in migrants – the need to focus on both conditions	7
TB-related deaths among adults in Guinea-Bissau	7
Management of childhood MDR-TB in Europe and Central Asia: report of a Regional WHO meeting	7
Early line-probe assay using DNA specimens in patients with pulmonary TB	7
Assessment of TB treatment on patient well-being	7
Extrapulmonary TB: a 30-year observational study of an Italian cohort	7
Does BCG vaccination protect against infection with M. tuberculosis?	7

Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB	7
Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients	7
Impact of the COVID-19 pandemic on TB infection testing	7
Accelerating TB diagnosis during the COVID-19 pandemic	7
Factors associated with presenting to private sector care providers at the onset of TB symptoms	6
Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial	6
Clinical and imaging features of drug-susceptible and multidrug-resistant TB in Korean adults	6
Latent TB and depressive symptoms in household contacts of persons with active TB	6
The impact of COVID-19 on the TB response: data from the field	6
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease	6
Smoked drug use in patients with TB is associated with higher bacterial burden	6
Use of local data to evaluate TB contact investigation in Malawi	6
Costs of treating multidrug-resistant TB in California in 2022	6
Ultrasound-guided lymph node biopsy in smear-negative children and adolescents with suspected TB	6
Incidence of TB disease among persons who use drugs in California	6
Diabetes mellitus and TB – finding strategies to reduce the double burden of disease	6
Surgical treatment for non-tuberculous mycobacterial pulmonary disease: analysis of prognostic factors	6
Pulmonary TB and chronic pulmonary aspergillosis	6
Launch of a second wave of IJTLD Clinical Standards for Lung Health	6
Clinical characteristics and decortication outcomes of bacterial, tuberculous and fungal pleural infection	6
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings	6
Current status and future prospects of TB digital treatment adherence technology use in China	6
Differences in gender perception of smokeless tobacco	6
Treatment outcomes of multidrug-resistant TB with selective use of new drugs	6
Diagnosis of paediatric TB using Xpert^® MTB/RIF Ultra on fresh respiratory samples	6
An effective vaccine is only the first step: the need to create and sustain demand for TB vaccines	5
Diagnostic accuracy of an exhaled breath test for TB in hospitalized patients with cough or risk	5
Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease	5
Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?	5
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs	5
Cost-effectiveness of pretomanid-based regimen for highly drug- resistant TB in a low-burden setting	5
Multigene Mycobacterium tuberculosis cell-free DNA assay	5
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	5
Chronic pulmonary aspergillosis in patients with post-TB sequelae	5
Clinical and imaging characteristics associated with hospitalisation for post-TB lung disease	5
Xpert^® MTB/RIF Ultra: detection of extrapulmonary TB in a high-burden setting	5
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo	5
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil	5
Screening for active and latent TB among migrants in France	5
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts	5
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19	5
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	5
Outdoor air pollution and respiratory health	5
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	5
TB infection in adults with diabetes mellitus in Uganda	5
Risk factors for TB in Australia and their association with delayed treatment completion	5
Screening of refugees from Ukraine for TB: a TBnet survey	5
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study	5
Predictors of mortality in Ugandan children with TB, 2016–2021	5
The Asthma Drug Facility and the future management of asthma	5
Performance of the DECAF score in predicting hospital mortality due to acute exacerbations of COPD	5
TB screening, prevention and treatment cascade in a Malawi prison	4
Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi	4
Co-administration of treatment for drug-resistant TB and hepatitis C	4
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	4
TB testing in HIV-positive patients prior to antiretroviral treatment	4
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB	4
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	4
Low BMI increases all-cause mortality rates in patients with drug-resistant TB	4
Reducing the burden of TB among migrants to low TB incidence countries	4
Occupational transmission of TB infection during autopsy	4
Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial	4
Bridging the gap: key evidence needed to strengthen global policies to end TB	4
Favourable outcomes in RR-TB patients using BPaL and other WHO-recommended second-line anti-TB drugs	4
Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients	4
Drug susceptibility testing for TB using the Xpert MTB/XDR assay on stool specimens	4
Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape	4
Early mortality during rifampicin-resistant TB treatment	4
Obstructive sleep apnoea in the elderly: a significant problem that needs urgent attention	4
TB outpatient care in a high-income, low-incidence country	4
Measuring cough-related quality of life and cough frequency in pulmonary TB	4
Indoor pet allergen exposures modify the effects of chemical air pollutants on respiratory symptoms	4
Asthma and allergies in schoolchildren: data from the European SINPHONIE study	4
Isoniazid-resistant TB: treatment outcomes and impact of regimens with fluoroquinolones	4
Implementation of modified, all-oral shorter TB regimens in Armenia	4
Non-malignant occupational respiratory diseases and climate change	4
A non-invasive, sensitive assay for active TB: combined cell-free DNA detection and FluoroSpot assays	4
Travel history and challenges of screening for latent TB infection in child asylum seekers	3
Miliary TB in children and adolescents: a scoping review	3
Private pharmacy and community health worker engagement in the provision of TB services	3

Prevalence, knowledge and factors associated with shisha smoking among university students in Cameroon	3
Evaluation of the MolecuTech^® REBA MTB-XMDR kit for detection of pre-extensively drug-resistant TB	3
Literature Highlights	3
Impact and treatment of exacerbations in adults with bronchiectasis	3
Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children	3
Trends in TB and HIV care and treatment cascade, Kenya, 2008–2018	3
A roadmap for lifting restrictive measures for COVID-19	3
Evaluation of an automated specimen processing system for staining and culture for acid-fast bacilli	3
Geographic mobility and time to seeking care among people with TB in Limpopo, South Africa	3
Impact of lung function on treatment outcome in patients with TB	3
Feasibility and acceptability of asynchronous VOT among patients with MDR-TB	3
Using a mobile application to improve pediatric presumptive TB identification in western Kenya	3
Impact of revised definitions for extensively drug-resistant TB on disease classification	3
Management of suspected hypersensitivity reactions to anti-TB drugs	3
Decreasing time spent in airborne infection isolation during TB testing	3
Primary bedaquiline resistance in Karakalpakstan, Uzbekistan	3
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	3
Why TB programmes should assess for comorbidities, determinants and disability at the start and end of TB treatment	3
Age-period-cohort analysis of TB mortality in South Korea, 1983–2017	3
Caregiver willingness to give TPT to children living with drug-resistant TB patients	3
The profit driven system can only lead to inequality, poverty, hunger and TB	3
Pulmonary and pleural TB prevalence in pregnant women	3
Source case investigation can reduce the diagnostic gap for childhood TB	3
TB infection in healthcare workers – the reality of a Portuguese hospital	3
T-SPOT.TB performed in lymphnodal tissue for the diagnosis of lymphadenitic TB	3
Are schools prepared to manage students with an asthma attack?	3
Haematological indicators of mortality in people with community-acquired pneumonia living at high altitude	3
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	3
The hidden burden of miliary TB in children and adolescents	3
Compliance with new drug use and the effect of discrepant drug susceptibility testing on MDR/RR-TB treatment	3
Cytomegalovirus viral load as predictor of the clinical course of hypoxic pneumonia in children	3
Reply to: Observations on malnutrition and anti-TB drugs in Ghana	3
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	3
The timing of intravenous antibiotics and clinical outcomes of Mycobacterium abscessus complex lung diseases	3
Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria	3
Referral of presumptive TB among operators of community medicine outlets	3
Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae	3
The COVID-19 pandemic does not bode well for TB control	3
Screening with GenoType^® MTBDRplus shortens the time to MDR-TB treatment initiation but does not change outcomes	3
Randomised-controlled trials and real-world evidence for optimising TB management	3
A novel home-based method for preparing suspensions of anti-TB drugs	3
Finding TB´s “missing millions”, one district at a time	3
Performance of spirometry assessment at TB diagnosis	3
Iqbal Haroon Master, 1962–2021	3
Assessing patient satisfaction with video-supported therapy for drug-susceptible TB treatment	3
Interventions to enhance treatment adherence and retention in care for HIV-TB	3
Use of rapid molecular TB diagnostics for incarcerated people in Brazil	3
Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?	3
Uptake of the lateral flow urine LAM test in Europe and Central Asia	2
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis	2
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function	2
Successes and challenges of latent TB screening and treatment in a high-prevalence US region	2
Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting	2
Best practices for the care of pregnant people living with TB	2
Cost of TB services in the public and private sectors in Georgia (No 2)	2
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	2
Nirmatrelvir/ritonavir and pharmacovigilance data	2
Number needed to screen for TB in clinical, structural or occupational risk groups	2
Tackling TB in Europe: treatment gaps and deteriorating treatment availability is undermining progress	2
Co-testing a single sputum specimen for TB and SARS-CoV-2	2
Medicinal plant use and adherence problems to TB treatment	2
Concomitant pulmonary disease is common among patients with extrapulmonary TB	2
The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV	2
Avoiding pitfalls in calculating the population attributable fraction of undernutrition for TB	2
Initial experience with BPaL-based regimens to treat multidrug-resistant TB	2
Compliance of vendors with legislation restricting the sale of tobacco near educational institutions in India	2
Programmatic implications of a sub-national TB prevalence survey in India	2
Perceived stigma among people with TB and household contacts	2
Gender differences in health-seeking behaviour, diagnosis and treatment for TB	2
Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan	2
Stool-based Xpert testing for diagnosis of TB in children and critically ill adults	2
Use of chest radiography screening for TB: a re-evaluation of the Kolín study	2
Emphasis on post-TB lung disease and other sequelae of TB is good but a public health approach to TB is morally ambitious	2
Low-cost air quality portable sensors and their potential use in respiratory health	2
Post-TB health and wellbeing	2
Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013–2020	2
Post-TB bronchiectasis: clinical characteristics and microbiology	2
Reply to Furin et al.: Clinical standards that are appropriate for all settings	2
Ten common myths about drug-susceptible TB	2
Challenges and opportunities for TB elimination in Suriname	2
Treatment success among Myanmar migrants with TB in Thailand	2
Mediastinal mycobacterial lymphadenitis and endoscopic ultrasound-guided needle aspiration techniques	2
Omadacycline enhances the in vitro activity of clofazimine against Mycobacterium abscessus	2
Hospitalizations with TB, California, 2009–2017	2
Assessment of asthma control in users of oral anti-asthma medications	2
Standards for clinical trials for treating TB	2
Thrombotic events and COVID-19 vaccines	2
Nosocomial TB in two neonatal intensive care units at a tertiary care centre: infection risk and outcomes	2
Disseminated TB: still being missed and misunderstood	2
Introduction of new drugs for drug-resistant TB in Iraq	2
The importance of pharmacokinetics/pharmacodynamics assessment in Phase IIB/III trials for MDR-TB treatment	2
Health-related quality of life and its effect on TB treatment outcomes	2
Paediatric TB care in the United Kingdom	2
The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London	2
Monitoring TB infection in contact cases: the impact of the COVID-19 pandemic	2